Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 12/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TYR | P14679 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | RARA | P10276 | 1/20 | 0.30 |
| ▸ | RARG | P13631 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3811731 | 0.89 | ESR2 (0.43) | CYP2C9ESR2CA2CA1ALDH1A1 | |
| SCHEMBL3816901 | 0.83 | ALDH1A1 (0.43) | CYP2C9ESR2ALDH1A1TYRRARG | |
| SCHEMBL3815507 | 0.82 | ESR2 (0.38) | CYP2C9ESR2CA2CA1ALDH1A1 | |
| SCHEMBL27849742 | 0.80 | ESR2 (0.39) | CYP2C9ESR2 | |
| SCHEMBL503351 | 0.79 | ESR2 (0.44) | CYP2C19ESR2 | |
| SCHEMBL3809156 | 0.79 | ESR2 (0.35) | CYP1A2CYP2C9CYP2C19ESR2ALDH1A1 | |
| SCHEMBL3815581 | 0.78 | ESR2 (0.39) | CYP2C9ESR2ALDH1A1TYR | |
| SCHEMBL2721633 | 0.77 | ESR2 (0.57) | CYP2C9ESR2 | |
| SCHEMBL3807403 | 0.76 | CA1 (0.42) | CYP1A2CYP2C9CYP2C19ESR2CA2 | |
| SCHEMBL3824336 | 0.75 | ESR2 (0.49) | CYP1A2CYP2C9CYP2C19ESR2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1375461-B1 | DIPHENOL AND PROCESS FOR PRODUCING THE SAME | HONSHU CHEMICAL IND (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-6872858-B2 | Diphenol and process for producing the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2005-03-29 | — | — | US | disclosed |
| US-20040049086-A1 | Diphenol and process for producing the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-03-11 | — | — | US | disclosed |
| EP-1375461-A1 | DIPHENOL AND PROCESS FOR PRODUCING THE SAME | Honshu Chemical Industry Co. Ltd. (JP) | 2004-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040049086-A1 | Diphenol and process for producing the same | CYP1A1, AHR, CYP2E1 | CYP1A2 23/4885CYP2C9 140/4885CYP2C19 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.